Sites of metastasis (mets) and association with clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).

被引：0
作者：
Martini, Dylan J.
Shabto, Julie M.
Liu, Yuan
Carthon, Bradley Curtis
Speak, Alexandra
Hitron, Elise
Russler, Greta
Caulfield, Sarah
Ogan, Kenneth
Harris, Wayne
Master, Viraj A.
Kucuk, Omer
Bilen, Mehmet Asim
机构：
[1] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA
[2] Emory Univ, Dept Biostat, Atlanta, GA 30322 USA
[3] Emory Univ, Dept Bioinformat, Atlanta, GA 30322 USA
[4] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[5] Emory Univ, Sch Med, Dept Pharmaceut Serv, Atlanta, GA USA
[6] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.585
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
585
引用
收藏
页数：2
相关论文
共 50 条
[31]   Effect of CBM588 in combination with cabozantinib plus nivolumab for patients (pts) with metastatic renal cell carcinoma (mRCC): A randomized clinical trial. [J].
Ebrahimi, Hedyeh ;
Meza, Luis A. ;
Lee, Keehoon ;
Malhotra, Jasnoor ;
Alcantara, Marice ;
Zengin, Zeynep Busra ;
Dizman, Nazli ;
Govindarajan, Ameish ;
Hsu, Joann ;
Llamas-Quitiquit, Marian ;
Chawla, Neal Shiv ;
Castro, Daniela V. ;
Mercier, Benjamin D. ;
Liu, Sandy ;
Chehrazi-Raffle, Alex ;
Dorff, Tanya B. ;
Frankel, Paul Henry ;
Li, Xiaochen ;
Pal, Sumanta Kumar ;
Tripathi, Abhishek .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17)
[32]   Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma (mRCC): Association of biomarkers with clinical outcomes [J].
Choueiri, Toni K. ;
Fishman, Mayer N. ;
Escudier, Bernard ;
McDermott, David F. ;
Kluger, Harriet M. ;
Stadler, Walter Michael ;
Perez-Gracia, Jose Luis ;
McNeel, Douglas G. ;
Curti, Brendan D. ;
Harrison, Michael Roger ;
Plimack, Elizabeth R. ;
Appleman, Leonard Joseph ;
Fong, Lawrence ;
Drake, Charles G. ;
Young, Tina C. ;
Chasalow, Scott D. ;
Ross-Macdonald, Petra ;
Simon, Jason S. ;
Walker, Dana ;
Sznol, Mario .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[33]   IMMUNOMODULATORY ACTIVITY OF NIVOLUMAB IN METASTATIC RENAL CELL CARCINOMA (MRCC): ASSOCIATION OF BIOMARKERS WITH CLINICAL OUTCOMES [J].
Choueri, Toni K. ;
Fishman, Mayer N. ;
Escudier, Bernard ;
McDermott, David F. ;
Kluger, Harriet ;
Stadler, Walter M. ;
Perez-Gracia, Jose L. ;
McNeel, Douglas ;
Curti, Brendan ;
Harrison, Michael R. ;
Plimack, Elizabeth R. ;
Appleman, Leonard ;
Fong, Lawrence ;
Drake, Charles G. ;
Young, Tina C. ;
Chasalow, Scott D. ;
Ross-Macdonald, Petra ;
Simon, Jason S. ;
Walker, Dana ;
Sznol, Mario .
Asia-Pacific Journal of Clinical Oncology, 2015, 11 :119-119
[34]   SUNITINIB IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS (PTS) WITH BRAIN METASTASES (METS): DATA FROM AN EXPANDED-ACCESS STUDY [J].
Bracarda, S. ;
Hariharan, S. ;
Szczylik, C. ;
Porta, C. ;
Hawkins, R. ;
Bjarnason, G. A. ;
Oudard, S. ;
Lee, S. H. ;
Carteni, G. ;
Gore, M. .
EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) :182-182
[35]   Immune cell changes in the peripheral blood of metastatic renal cell carcinoma (mRCC) patients (pts) treated with sunitinib or temsirolimus [J].
Salas, R. N. ;
Ireland, J. L. ;
Ko, J. S. ;
Elson, P. ;
Garcia, J. A. ;
Wood, L. ;
Bukowski, R. M. ;
Rini, B. I. ;
Finke, J. H. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[36]   Metastatic renal cell carcinoma (mRCC) patients (pts) with sarcomatoid features treated with VEGF-targeted therapy [J].
Golshayan, A. R. ;
George, S. ;
Heng, D. Y. ;
Elson, P. ;
Wood, L. ;
Garcia, J. A. ;
Aydin, H. ;
Zhou, M. ;
Bukowski, R. M. ;
Rini, B. I. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[37]   Impact of metformin on outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC): Results from a pooled clinical trials database. [J].
Hamieh, Lana ;
Mckay, Rana R. ;
Mickey, Suzanne S. ;
Lin, Xun ;
Simantov, Ronit ;
Choueiri, Toni K. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[38]   Efficacy and safety of everolimus in elderly patients (pts) with metastatic renal cell carcinoma (mRCC) [J].
Osanto, S. ;
Hutson, T. E. ;
Calvo, E. ;
Escudier, B. J. ;
Oudard, S. ;
Porta, C. ;
Bracarda, S. ;
Grunwald, V. ;
Ravaud, A. ;
Motzer, R. J. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[39]   Outcomes of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with pazopanib after progression on other targeted therapies (TT): Updated results [J].
Matrana, Marc Ryan ;
Duran, Cihan ;
Shetty, Aditya ;
Xiao, Lianchun ;
Atkinson, Bradley J. ;
Corn, Paul G. ;
Charnsangavej, Chusilp ;
Jonasch, Eric ;
Tannir, Nizar M. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
[40]   Retrospective analysis of risk factors for fatigue in clinical trial patients (pts) with metastatic renal cell carcinoma (mRCC). [J].
Gore, Martin Eric ;
Gruenwald, Viktor ;
Motzer, Robert John ;
Quinn, David I. ;
Rini, Brian I. ;
Lin, Xun ;
Perkins, Julia Jane ;
Simantov, Ronit ;
Choueiri, Toni K. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345